COVID-19 adverse outcome pathway (WP4891)

Homo sapiens

Experimenting with links in line with bioinformatics analysis of COVID-19 genes and AOP knowledge. Work in progress!


Penny Nymark , Friederike Ehrhart , Egon Willighagen , Chris Evelo , and Eric Weitz


last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.


Homo sapiens


Adverse Outcome Pathways COVID-19


Disease Ontology

severe acute respiratory syndrome pulmonary fibrosis viral infectious disease COVID-19

Pathway Ontology

respiratory system disease pathway signaling pathway


Label Type Compact URI Comment
CCL3 GeneProduct ncbigene:6348
TNF GeneProduct ncbigene:7124
IL2 GeneProduct ncbigene:3558
CSF3 GeneProduct ncbigene:1440
IL8 GeneProduct ncbigene:3576
CXCL10 GeneProduct ncbigene:3627
IL6 GeneProduct ncbigene:3569
IL7 GeneProduct ncbigene:3574
IL1B GeneProduct ncbigene:3553
CCL2 GeneProduct ncbigene:6347
IL10 GeneProduct ncbigene:3586
IL2RA GeneProduct ncbigene:3559
AGT GeneProduct ncbigene:183
TMPRSS2 GeneProduct ncbigene:7113
ACE2 GeneProduct ncbigene:59272


  1. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. Circ Res. 2000 Sep 1;87(5):E1-9. PubMed Europe PMC Scholia
  2. Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes. Labib S, Williams A, Yauk CL, Nikota JK, Wallin H, Vogel U, et al. Part Fibre Toxicol. 2016 Mar 15;13:15. PubMed Europe PMC Scholia
  3. A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions. Nymark P, Rieswijk L, Ehrhart F, Jeliazkova N, Tsiliki G, Sarimveis H, et al. Toxicol Sci. 2018 Mar 1;162(1):264–75. PubMed Europe PMC Scholia